CoChat

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a target for antiviral therapy

Open access

Abstract

The imminent threat of viral epidemics and pandemics dictates a need for therapeutic approaches that target viral pathology irrespective of the infecting strain. Reactive oxygen species are ancient processes that protect plants, fungi and animals against invading pathogens including bacteria. However, in mammals reactive oxygen species production paradoxically promotes virus pathogenicity by mechanisms not yet defined. Here we identify that the primary enzymatic source of reactive oxygen species, NOX2 oxidase, is activated by single stranded RNA and DNA viruses in endocytic compartments resulting in endosomal hydrogen peroxide generation, which suppresses antiviral and humoral signaling networks via modification of a unique, highly conserved cysteine residue (Cys98) on Toll-like receptor-7. Accordingly, targeted inhibition of endosomal reactive oxygen species production abrogates influenza A virus pathogenicity. We conclude that endosomal reactive oxygen species promote fundamental molecular mechanisms of viral pathogenicity, and the specific targeting of this pathogenic process with endosomal-targeted reactive oxygen species inhibitors has implications for the treatment of viral disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-017-00057-x

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Seasonal and pandemic influenza A viruses induce endosomal ROS production via activation of NOX2 oxidase. a, b Confocal microscopy of wild-type (WT) mouse primary alveolar macrophages that were infected with influenza A virus strain HKx31 (MOI of 10) for 1 h and labeled with antibody to the early endosome antigen 1 (EEA1) and antibodies to either a influenza A virus nucleoprotein (NP) or b NOX2, and then with 4′,6′-diamidino-2-phenylindole (DAPI; blue). Also shown is the quantification of results (n = 5). c, d Time-dependent elevation in endosomal ROS levels in mouse primary alveolar macrophages as assessed by OxyBURST (100 μM) confocal fluorescence microscropy and labeled with DAPI (n = 5). e, f Endosomal ROS production in WT, NOX2−/y and superoxide dismutase (SOD; 300 U/ml)-treated WT mouse primary alveolar macrophages as assessed by OxyBURST confocal fluorescence microscopy in the absence or presence of HKx31 virus and labeled with DAPI (n = 5). g Uninfected and HKx31 virus-infected mouse primary alveolar macrophages were labeled with OxyBURST and the acidified endosome marker Lysotracker (50 nM). Some cells were treated with bafilomycin A (Baf-A; 100 nM) to suppress acidification of endosomes (n = 4). h Human alveolar macrophages infected with seasonal H3N2 (A/New York/55/2004, A/Brisbane/9/2007), seasonal H1N1 (A/New Caledonia/20/1999, A/Solomon Islands/3/2006) and pandemic A(H1N1) pdm09 strains (A/California/7/2009, A/Auckland/1/2009) and labeled with OxyBURST for endosomal ROS (n = 4). i, j Endosomal ROS production in WT mouse primary alveolar macrophages as assessed by OxyBURST fluorescence microscopy exposed to either heat (56 ºC)-inactivated HKx-31 virus (to block virus fusion) or UV-inactivated HKx-31 virus (to block replication) and labeled with DAPI (n = 4). a–i Images are representative of >150 cells analyzed over each experiment. Original magnification ×100. a, b, d, f and j Data are represented as mean ± S.E.M. a and b Students’ unpaired t-test *P < 0.05. d, f and j One-way ANOVA followed by Dunnett’s post hoc test for multiple comparisons. *P < 0.05 and **P < 0.01. Scale bars: 10 µm
Fig. 1 Seasonal and pandemic influenza A viruses induce endosomal ROS production via activation of NOX2 oxidase. a, b Confocal microscopy of wild-type (WT) mouse primary alveolar macrophages that were infected with influenza A virus strain HKx31 (MOI of 10) for 1 h and labeled with antibody to the early endosome antigen 1 (EEA1) and antibodies to either a influenza A virus nucleoprotein (NP) or b NOX2, and then with 4′,6′-diamidino-2-phenylindole (DAPI; blue). Also shown is the quantification of results (n = 5). c, d Time-dependent elevation in endosomal ROS levels in mouse primary alveolar macrophages as assessed by OxyBURST (100 μM) confocal fluorescence microscropy and labeled with DAPI (n = 5). e, f Endosomal ROS production in WT, NOX2−/y and superoxide dismutase (SOD; 300 U/ml)-treated WT mouse primary alveolar macrophages as assessed by OxyBURST confocal fluorescence microscopy in the absence or presence of HKx31 virus and labeled with DAPI (n = 5). g Uninfected and HKx31 virus-infected mouse primary alveolar macrophages were labeled with OxyBURST and the acidified endosome marker Lysotracker (50 nM). Some cells were treated with bafilomycin A (Baf-A; 100 nM) to suppress acidification of endosomes (n = 4). h Human alveolar macrophages infected with seasonal H3N2 (A/New York/55/2004, A/Brisbane/9/2007), seasonal H1N1 (A/New Caledonia/20/1999, A/Solomon Islands/3/2006) and pandemic A(H1N1) pdm09 strains (A/California/7/2009, A/Auckland/1/2009) and labeled with OxyBURST for endosomal ROS (n = 4). i, j Endosomal ROS production in WT mouse primary alveolar macrophages as assessed by OxyBURST fluorescence microscopy exposed to either heat (56 ºC)-inactivated HKx-31 virus (to block virus fusion) or UV-inactivated HKx-31 virus (to block replication) and labeled with DAPI (n = 4). a–i Images are representative of >150 cells analyzed over each experiment. Original magnification ×100. a, b, d, f and j Data are represented as mean ± S.E.M. a and b Students’ unpaired t-test *P < 0.05. d, f and j One-way ANOVA followed by Dunnett’s post hoc test for multiple comparisons. *P < 0.05 and **P < 0.01. Scale bars: 10 µmCC BY · PubMed Central
Fig. 2 Co-localization of TLR7 with influenza A virus, NOX2 and EEA1 is a signaling platform for endosomal ROS generation to influenza A virus via a TLR7 and PKC-dependent mechanism. a–c Confocal microscopy of mouse primary alveolar macrophages that were untreated or infected with influenza A virus HKx31 (MOI of 10) and labeled with antibodies to TLR7 and either a influenza A virus NP, b NOX2 or c EEA1, and then with 4′,6′-diamidino-2-phenylindole (DAPI). Quantification data from multiple experiments are also shown (n = 5). d Endosomal ROS production in WT and TLR7−/− mouse primary alveolar macrophages as assessed by Oxyburst (100 μM) fluorescence microscopy in the absence or presence of HKx31 virus and labeled with DAPI (n = 6). e Immunofluorescence microscopy for assessment of NOX2 and p47phox association. WT and TLR7−/− immortalized bone marrow-derived macrophages (BMDMs) were untreated or infected with HKx31 virus, (MOI of 10) in the absence or presence of bafilomycin A (Baf-A; 100 nM) or dynasore (Dyna; 100 μM), and then labeled with antibodies to NOX2 and p47phox. Also shown is the quantification of the results (n = 5). f, g Endosomal ROS production in WT and NOX2−/y mouse primary alveolar macrophages as assessed by Oxyburst fluorescence microscopy in the absence or presence of f imiquimod (Imiq; 10 μg/ml) and g ssRNA (100 μg/ml) and co-labeled with DAPI. (n = 5). h, i Cytosolic PKC activity as assessed by FRET analysis in WT and TLR7−/− BMDMs. Cells were either treated with vehicle controls or with bafilomycin A (100 nM) or dynasore (10 μM) and then exposed for 25 min to influenza A virus (HKx31, MOI of 10) or imiquimod (10 μg/ml) (n = 3). a–g Images are representative of >150 cells analyzed over each experiment. Original magnification ×100. All data are represented as mean ± S.E.M. a, b, c, f and g Student’s unpaired t-test *P < 0.05. d, e, h and i One-way ANOVA followed by Dunnett’s post hoc test for multiple comparisons. *P < 0.05. Scale bars: 10 µm
Fig. 2 Co-localization of TLR7 with influenza A virus, NOX2 and EEA1 is a signaling platform for endosomal ROS generation to influenza A virus via a TLR7 and PKC-dependent mechanism. a–c Confocal microscopy of mouse primary alveolar macrophages that were untreated or infected with influenza A virus HKx31 (MOI of 10) and labeled with antibodies to TLR7 and either a influenza A virus NP, b NOX2 or c EEA1, and then with 4′,6′-diamidino-2-phenylindole (DAPI). Quantification data from multiple experiments are also shown (n = 5). d Endosomal ROS production in WT and TLR7−/− mouse primary alveolar macrophages as assessed by Oxyburst (100 μM) fluorescence microscopy in the absence or presence of HKx31 virus and labeled with DAPI (n = 6). e Immunofluorescence microscopy for assessment of NOX2 and p47phox association. WT and TLR7−/− immortalized bone marrow-derived macrophages (BMDMs) were untreated or infected with HKx31 virus, (MOI of 10) in the absence or presence of bafilomycin A (Baf-A; 100 nM) or dynasore (Dyna; 100 μM), and then labeled with antibodies to NOX2 and p47phox. Also shown is the quantification of the results (n = 5). f, g Endosomal ROS production in WT and NOX2−/y mouse primary alveolar macrophages as assessed by Oxyburst fluorescence microscopy in the absence or presence of f imiquimod (Imiq; 10 μg/ml) and g ssRNA (100 μg/ml) and co-labeled with DAPI. (n = 5). h, i Cytosolic PKC activity as assessed by FRET analysis in WT and TLR7−/− BMDMs. Cells were either treated with vehicle controls or with bafilomycin A (100 nM) or dynasore (10 μM) and then exposed for 25 min to influenza A virus (HKx31, MOI of 10) or imiquimod (10 μg/ml) (n = 3). a–g Images are representative of >150 cells analyzed over each experiment. Original magnification ×100. All data are represented as mean ± S.E.M. a, b, c, f and g Student’s unpaired t-test *P < 0.05. d, e, h and i One-way ANOVA followed by Dunnett’s post hoc test for multiple comparisons. *P < 0.05. Scale bars: 10 µmCC BY · PubMed Central
Fig. 3 Endosomal ROS production to ssRNA and DNA viruses are via TLR7 and TLR9-dependent mechanisms, respectively. a Endosomal ROS production in WT and TLR7−/− bone marrow-derived macrophages as assessed by OxyBURST (100 μM) fluorescence microscopy in the absence or presence of influenza A virus (HKx31 virus), rhinovirus (rhino), respiratory synctitial virus (RSV), human parainfluenza virus (PIV), human metapneumovirus (HMPV), sendai virus, dengue virus, human immunodeficiency virus (HIV), mumps virus (MuV), Newcastle disease virus (NDV), rotavirus (UK and bovine strains), herpes simplex virus 2 (HSV-2), and vaccinia virus and labeled with 4′,6′-diamidino-2-phenylindole (DAPI). Also shown is the quantification of the results (n = 5). b Endosomal ROS production in WT and TLR9−/− mouse primary alveolar macrophages as assessed by OxyBURST fluorescence microscopy in the absence or presence of HKx31 virus, rhinovirus, sendai virus, dengue virus, and herpes simplex virus 2 (HSV-2) and labeled with DAPI (n = 5). a and b Images are representative of >150 cells analyzed over each experiment. Original magnification ×100. All data are represented as mean ± S.E.M. One-way ANOVA followed by Dunnett’s post hoc test for multiple comparisons. # P < 0.05 compared to WT control. *P < 0.05 comparisons indicated by horizontal bars. Scale bars: 10 µm
Fig. 3 Endosomal ROS production to ssRNA and DNA viruses are via TLR7 and TLR9-dependent mechanisms, respectively. a Endosomal ROS production in WT and TLR7−/− bone marrow-derived macrophages as assessed by OxyBURST (100 μM) fluorescence microscopy in the absence or presence of influenza A virus (HKx31 virus), rhinovirus (rhino), respiratory synctitial virus (RSV), human parainfluenza virus (PIV), human metapneumovirus (HMPV), sendai virus, dengue virus, human immunodeficiency virus (HIV), mumps virus (MuV), Newcastle disease virus (NDV), rotavirus (UK and bovine strains), herpes simplex virus 2 (HSV-2), and vaccinia virus and labeled with 4′,6′-diamidino-2-phenylindole (DAPI). Also shown is the quantification of the results (n = 5). b Endosomal ROS production in WT and TLR9−/− mouse primary alveolar macrophages as assessed by OxyBURST fluorescence microscopy in the absence or presence of HKx31 virus, rhinovirus, sendai virus, dengue virus, and herpes simplex virus 2 (HSV-2) and labeled with DAPI (n = 5). a and b Images are representative of >150 cells analyzed over each experiment. Original magnification ×100. All data are represented as mean ± S.E.M. One-way ANOVA followed by Dunnett’s post hoc test for multiple comparisons. # P < 0.05 compared to WT control. *P < 0.05 comparisons indicated by horizontal bars. Scale bars: 10 µmCC BY · PubMed Central
Fig. 4 Bacteria-induced ROS production is distinct from virus-dependent ROS mechanisms. a Phagosomal superoxide production to Haemophilus influenzae and Streptococcus pneumoniae as assessed by OxyBURST (100 μM) fluorescence microscopy in WT and TLR7−/− immortalized bone marrow derived macrophages. Images are representative of >150 cells analyzed over each experiment. Original magnification ×100. b Is the quantification of the results (n = 5). All data are represented as mean ± S.E.M. One-way ANOVA followed by Dunnett’s post hoc test for multiple comparisons. *P < 0.05 compared to WT control. Scale bar: 10 µm
Fig. 4 Bacteria-induced ROS production is distinct from virus-dependent ROS mechanisms. a Phagosomal superoxide production to Haemophilus influenzae and Streptococcus pneumoniae as assessed by OxyBURST (100 μM) fluorescence microscopy in WT and TLR7−/− immortalized bone marrow derived macrophages. Images are representative of >150 cells analyzed over each experiment. Original magnification ×100. b Is the quantification of the results (n = 5). All data are represented as mean ± S.E.M. One-way ANOVA followed by Dunnett’s post hoc test for multiple comparisons. *P < 0.05 compared to WT control. Scale bar: 10 µmCC BY · PubMed Central
Fig. 5 Endosomal NOX2 oxidase suppresses cytokine expression in response to TLR7 activation in vitro and in vivo. a, b WT and TLR7−/− immortalized bone marrow-derived macrophages (BMDMs) were untreated or treated with imiquimod (Imiq; 10 μg/ml) in the absence or presence of a apocynin (Apo; 300 μM) or b bafilomycin A (Baf-A; 100 nM), and IFN-β, IL-1β, TNF-α and IL-6 mRNA expression determined by QPCR after 24 h (n = 6). c, d WT and NOX2−/y mice were administered with imiquimod (50 μg per mouse, intranasal) and c total airway inflammation quantified by bronchoalveolar lavage fluid analysis and d cytokine expression assessed 24 h later (n = 5). a, b, d Responses are relative to GAPDH and then expressed as a fold-change above WT controls. a–d Data are represented as mean ± S.E.M. a, b and d Kruskal–Wallis test with Dunn’s post hoc for multiple comparisons. c One-way ANOVA followed by Dunnett’s post hoc test for multiple comparisons. Statistical significance was accepted when P < 0.05. *P < 0.05; **P < 0.01
Fig. 5 Endosomal NOX2 oxidase suppresses cytokine expression in response to TLR7 activation in vitro and in vivo. a, b WT and TLR7−/− immortalized bone marrow-derived macrophages (BMDMs) were untreated or treated with imiquimod (Imiq; 10 μg/ml) in the absence or presence of a apocynin (Apo; 300 μM) or b bafilomycin A (Baf-A; 100 nM), and IFN-β, IL-1β, TNF-α and IL-6 mRNA expression determined by QPCR after 24 h (n = 6). c, d WT and NOX2−/y mice were administered with imiquimod (50 μg per mouse, intranasal) and c total airway inflammation quantified by bronchoalveolar lavage fluid analysis and d cytokine expression assessed 24 h later (n = 5). a, b, d Responses are relative to GAPDH and then expressed as a fold-change above WT controls. a–d Data are represented as mean ± S.E.M. a, b and d Kruskal–Wallis test with Dunn’s post hoc for multiple comparisons. c One-way ANOVA followed by Dunnett’s post hoc test for multiple comparisons. Statistical significance was accepted when P < 0.05. *P < 0.05; **P < 0.01CC BY · PubMed Central
Fig. 6 Endosomal NOX2 oxidase-derived hydrogen peroxide (H2O2) inhibits cytokine expression in response to TLR7 activation in vitro and in vivo. a WT mouse primary alveolar macrophages were either left untreated or treated with FITC-labeled catalase for 5 min prior to infection with HKx31 virus (MOI of 10). Cells were labeled for Lysotracker (50 nM) and colocalization of Lysotracker and FITC catalase assessed by confocal microscopy. Images are representative of >100 cells analyzed over each experiment. Original magnification ×100 (n = 3). b WT and TLR7−/− immortalized bone marrow-derived macrophages (BMDMs) were left untreated or treated for 1 h with catalase (1000 U/ml) and IFN-β and IL-1β, mRNA expression determined by QPCR after 24 h (n = 7). c WT BMDMs were left untreated or treated for 1 h with imiquimod (Imiq) in the absence or presence of catalase (1000 U/ml), IFN-β and IL-1β, mRNA expression assessed 24 h later by QPCR (n = 6). d WT BMDMs were treated for 30 min with either DMSO (0.1%) or dynasore (Dyna; 100 μM) and then with catalase (1000 U/ml) for 1 h. Cytokine mRNA expression determined by QPCR after 24 h (n = 6). e WT and TLR2−/− immortalized BMDMs were treated with catalase (1000 U/ml) for 1 h and cytokine mRNA expression determined by QPCR after 24 h (n = 6). f WT and UNCB93−/− immortalized BMDMs were treated with catalase (1000 U/ml) for 1 h and cytokine mRNA expression determined by QPCR after 24 h (n = 6). g–i WT BMDMs were treated for 1 h with either catalase or imiquimod (10 μg/ml) and g TLR7, h NLRP3 or i TREML4 mRNA expression determined by QPCR after 24 h (n = 6). j Mice were intranasally treated with catalase (1000 U per mouse) and then lung expression of TREML4 was determined by QPCR (n = 5). k and l Catalase (1000 U per mouse, intranasal) was administered to WT mice and k total BALF airway inflammation and l lung cytokine expression assessed 24 h later (n = 5). b–j and l Responses are relative to GAPDH and then expressed as a fold-change above WT controls. b–h and l Kruskal–Wallis test with Dunn’s post hoc for multiple comparisons. i and j Mann–Whitney Wilcoxon test. All data are represented as mean ± S.E.M. Statistical significance was taken when the P < 0.05. *P < 0.05. Scale bar: 10 µm
Fig. 6 Endosomal NOX2 oxidase-derived hydrogen peroxide (H2O2) inhibits cytokine expression in response to TLR7 activation in vitro and in vivo. a WT mouse primary alveolar macrophages were either left untreated or treated with FITC-labeled catalase for 5 min prior to infection with HKx31 virus (MOI of 10). Cells were labeled for Lysotracker (50 nM) and colocalization of Lysotracker and FITC catalase assessed by confocal microscopy. Images are representative of >100 cells analyzed over each experiment. Original magnification ×100 (n = 3). b WT and TLR7−/− immortalized bone marrow-derived macrophages (BMDMs) were left untreated or treated for 1 h with catalase (1000 U/ml) and IFN-β and IL-1β, mRNA expression determined by QPCR after 24 h (n = 7). c WT BMDMs were left untreated or treated for 1 h with imiquimod (Imiq) in the absence or presence of catalase (1000 U/ml), IFN-β and IL-1β, mRNA expression assessed 24 h later by QPCR (n = 6). d WT BMDMs were treated for 30 min with either DMSO (0.1%) or dynasore (Dyna; 100 μM) and then with catalase (1000 U/ml) for 1 h. Cytokine mRNA expression determined by QPCR after 24 h (n = 6). e WT and TLR2−/− immortalized BMDMs were treated with catalase (1000 U/ml) for 1 h and cytokine mRNA expression determined by QPCR after 24 h (n = 6). f WT and UNCB93−/− immortalized BMDMs were treated with catalase (1000 U/ml) for 1 h and cytokine mRNA expression determined by QPCR after 24 h (n = 6). g–i WT BMDMs were treated for 1 h with either catalase or imiquimod (10 μg/ml) and g TLR7, h NLRP3 or i TREML4 mRNA expression determined by QPCR after 24 h (n = 6). j Mice were intranasally treated with catalase (1000 U per mouse) and then lung expression of TREML4 was determined by QPCR (n = 5). k and l Catalase (1000 U per mouse, intranasal) was administered to WT mice and k total BALF airway inflammation and l lung cytokine expression assessed 24 h later (n = 5). b–j and l Responses are relative to GAPDH and then expressed as a fold-change above WT controls. b–h and l Kruskal–Wallis test with Dunn’s post hoc for multiple comparisons. i and j Mann–Whitney Wilcoxon test. All data are represented as mean ± S.E.M. Statistical significance was taken when the P < 0.05. *P < 0.05. Scale bar: 10 µmCC BY · PubMed Central
Fig. 7 C98 on TLR7 regulates activity of the receptor and is a target for endosomal H2O2. a TLR7−/− BMDMs were transfected with empty vector, WT TLR7 or with either TLR7 with cysteines 98, 260, 263, 270, 273, and 445 mutated to alanine (TLR7 6 mut), TLR7 with cysteines 98 and 445 mutated to alanine (TLR7C98A/445 A) or with TLR7 with cysteines 445 (TLR7C445A) or 98 (TLR7C98A) mutated to alanine. After 48 h, cells were left untreated or treated for 1 h with either catalase (1000 U/ml) or imiquimod (Imiq, 10 μg/ml) and cytokine expression assessed 24 h later (n = 6). Responses are relative to GAPDH and then expressed as a fold-change above TLR7−/− controls. Data are represented as mean ± S.E.M. One-way ANOVA followed by Dunnett’s post hoc test for multiple comparisons. Statistical significance was accepted when P < 0.05. *P < 0.05. (NS) Denotes not significant. b Multiple sequence alignment with CLUSTAL OMEGA showing across species conservation of Cys 98 on TLR7
Fig. 7 C98 on TLR7 regulates activity of the receptor and is a target for endosomal H2O2. a TLR7−/− BMDMs were transfected with empty vector, WT TLR7 or with either TLR7 with cysteines 98, 260, 263, 270, 273, and 445 mutated to alanine (TLR7 6 mut), TLR7 with cysteines 98 and 445 mutated to alanine (TLR7C98A/445 A) or with TLR7 with cysteines 445 (TLR7C445A) or 98 (TLR7C98A) mutated to alanine. After 48 h, cells were left untreated or treated for 1 h with either catalase (1000 U/ml) or imiquimod (Imiq, 10 μg/ml) and cytokine expression assessed 24 h later (n = 6). Responses are relative to GAPDH and then expressed as a fold-change above TLR7−/− controls. Data are represented as mean ± S.E.M. One-way ANOVA followed by Dunnett’s post hoc test for multiple comparisons. Statistical significance was accepted when P < 0.05. *P < 0.05. (NS) Denotes not significant. b Multiple sequence alignment with CLUSTAL OMEGA showing across species conservation of Cys 98 on TLR7CC BY · PubMed Central
Fig. 8 Inhibition of NOX2 oxidase increases expression of Type I IFN and IL-1β, and antibody production to influenza A virus infection. a Alveolar macrophages from WT and Nox2−/y mice were either left untreated (naïve) or infected with HKx31 influenza A virus (MOI of 10) for analysis of IFN-β, IL-1β, TNF-α, and IL-6 mRNA expression by QPCR after 24 h (n = 8). b, c WT and Nox2−/y mice were infected with live HKx31 influenza A virus (1 × 105 PFU per mouse) and b cytokine mRNA expression and IFN-β protein expression in c BALF or d serum were assessed 3 days later (n = 5). e–i WT and Nox2−/y mice were infected with inactivated HKx31 influenza A virus (equivalent to 1 × 104 PFU per mouse) for measurements at day 7 of: e body weight; f airway inflammation and differential cell counts (i.e., macrophages, neutrophils, and lymphocytes); g cytokine expression in whole lung (responses are shown as fold change relative to GAPDH) and h serum and i BALF antibody levels (n = 6). Data are shown as mean ± SE. a Kruskal–Wallis test with Dunn’s post hoc for multiple comparisons. b–i Unpaired t-test; statistical significance taken when the P < 0.05. *P < 0.05. **P < 0.01
Fig. 8 Inhibition of NOX2 oxidase increases expression of Type I IFN and IL-1β, and antibody production to influenza A virus infection. a Alveolar macrophages from WT and Nox2−/y mice were either left untreated (naïve) or infected with HKx31 influenza A virus (MOI of 10) for analysis of IFN-β, IL-1β, TNF-α, and IL-6 mRNA expression by QPCR after 24 h (n = 8). b, c WT and Nox2−/y mice were infected with live HKx31 influenza A virus (1 × 105 PFU per mouse) and b cytokine mRNA expression and IFN-β protein expression in c BALF or d serum were assessed 3 days later (n = 5). e–i WT and Nox2−/y mice were infected with inactivated HKx31 influenza A virus (equivalent to 1 × 104 PFU per mouse) for measurements at day 7 of: e body weight; f airway inflammation and differential cell counts (i.e., macrophages, neutrophils, and lymphocytes); g cytokine expression in whole lung (responses are shown as fold change relative to GAPDH) and h serum and i BALF antibody levels (n = 6). Data are shown as mean ± SE. a Kruskal–Wallis test with Dunn’s post hoc for multiple comparisons. b–i Unpaired t-test; statistical significance taken when the P < 0.05. *P < 0.05. **P < 0.01CC BY · PubMed Central
Fig. 9 Endosome targeted delivery of a NOX2 oxidase inhibitor protects mice following influenza A virus infection in vivo. a–e Alveolar macrophages from WT mice were treated with the Cy5 cholestanol-PEG linker fluorophore (Cy5-chol; 100 nM) for 30 min and infected with HKx31 influenza A virus (MOI of 10). Cells were then counter labeled with antibodies to either: a and b EEA1, c NOX2 or d influenza A nucleoprotein (NP). All cells were then stained with 4′,6′-diamidino-2-phenylindole (DAPI) and imaged with confocal microscopy. b Cells were pretreated with dynasore (100 μM) for 30 min prior to exposure to Cy5-cholestanol. e Quantification of data from (a–d, n = 5). f RAW 264.7 macrophages were either untreated or treated with various concentrations of cholestanol-conjugated gp91ds-TAT (Cgp91), ethyl conjugated gp91ds-TAT (Egp91) or unconjugated gp91ds-TAT (Ugp91) for 30 min prior to quantifying ROS production by L-O12 (100 μM)-enhanced chemiluminescence (n = 7). g Superoxide production via the xanthine/xanthine oxidase cell-free assay in the absence or presence of Ugp91ds-TAT, (1 μM) or Cgp91ds-TAT (1 μM) (n = 6). h, i Ugp91ds-TAT (0.02 mg/kg/day) or Cgp91ds-TAT (0.02 mg/kg/day) were delivered intranasally to WT mice once daily for 4 days. At 24 h after the first dose of inhibitor, mice were either treated with saline or infected with HKx31 influenza A virus (1 × 105 PFU per mouse). Mice were culled at day 3 post-infection and h airway inflammation was assessed by BALF cell counts and i lung IFN-β mRNA was determined by QPCR (n = 7). (NS) denotes not significant. j–m Mice were subjected to the NOX2 inhibitor treatment regime and virus infection protocol as in h except NOX2 inhibitors were delivered at a dose of 0.2 mg/kg/day (n = 7). Analysis of j airway inflammation by BALF counts, k body weight (% weight change from the value measured at Day -1), l ROS production by BALF inflammatory cells with L-O12 enhanced chemiluminescence and m viral mRNA by QPCR. Data are represented as mean ± S.E.M. e Unpaired t-test; statistical significance taken when the P < 0.05. f, g, h, j, k, l One-way ANOVA followed by Dunnett’s post hoc test for multiple comparisons. i and m Kruskal–Wallis test with Dunn’s post hoc for multiple comparisons. Statistical significance was accepted when P < 0.05. *P < 0.05; **P < 0.01. Scale bars: 10 µm
Fig. 9 Endosome targeted delivery of a NOX2 oxidase inhibitor protects mice following influenza A virus infection in vivo. a–e Alveolar macrophages from WT mice were treated with the Cy5 cholestanol-PEG linker fluorophore (Cy5-chol; 100 nM) for 30 min and infected with HKx31 influenza A virus (MOI of 10). Cells were then counter labeled with antibodies to either: a and b EEA1, c NOX2 or d influenza A nucleoprotein (NP). All cells were then stained with 4′,6′-diamidino-2-phenylindole (DAPI) and imaged with confocal microscopy. b Cells were pretreated with dynasore (100 μM) for 30 min prior to exposure to Cy5-cholestanol. e Quantification of data from (a–d, n = 5). f RAW 264.7 macrophages were either untreated or treated with various concentrations of cholestanol-conjugated gp91ds-TAT (Cgp91), ethyl conjugated gp91ds-TAT (Egp91) or unconjugated gp91ds-TAT (Ugp91) for 30 min prior to quantifying ROS production by L-O12 (100 μM)-enhanced chemiluminescence (n = 7). g Superoxide production via the xanthine/xanthine oxidase cell-free assay in the absence or presence of Ugp91ds-TAT, (1 μM) or Cgp91ds-TAT (1 μM) (n = 6). h, i Ugp91ds-TAT (0.02 mg/kg/day) or Cgp91ds-TAT (0.02 mg/kg/day) were delivered intranasally to WT mice once daily for 4 days. At 24 h after the first dose of inhibitor, mice were either treated with saline or infected with HKx31 influenza A virus (1 × 105 PFU per mouse). Mice were culled at day 3 post-infection and h airway inflammation was assessed by BALF cell counts and i lung IFN-β mRNA was determined by QPCR (n = 7). (NS) denotes not significant. j–m Mice were subjected to the NOX2 inhibitor treatment regime and virus infection protocol as in h except NOX2 inhibitors were delivered at a dose of 0.2 mg/kg/day (n = 7). Analysis of j airway inflammation by BALF counts, k body weight (% weight change from the value measured at Day -1), l ROS production by BALF inflammatory cells with L-O12 enhanced chemiluminescence and m viral mRNA by QPCR. Data are represented as mean ± S.E.M. e Unpaired t-test; statistical significance taken when the P < 0.05. f, g, h, j, k, l One-way ANOVA followed by Dunnett’s post hoc test for multiple comparisons. i and m Kruskal–Wallis test with Dunn’s post hoc for multiple comparisons. Statistical significance was accepted when P < 0.05. *P < 0.05; **P < 0.01. Scale bars: 10 µmCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Cited by

See all 154

Metadata

Authors
To, E. E., Vlahos, R., Luong, R., Halls, M. L., Reading, P. C., King, P. T., Chan, C., Drummond, G. R., Sobey, C. G., Broughton, B. R. S., Starkey, M. R., van der Sluis, R., Lewin, S. R., Bozinovski, S., O’Neill, L. A. J., Quach, T., Porter, C. J. H., Brooks, D. A., O’Leary, J. J., & Selemidis, S.
Affiliations
  • Monash University (AU)
  • RMIT University (AU)
  • The University of Melbourne (AU)
  • Monash Medical Centre (AU)
  • Harvard University (US)
  • La Trobe University (AU)
  • Hunter Medical Research Institute (AU)
  • The Royal Melbourne Hospital (AU)
  • University of South Australia (AU)
  • Trinity College Dublin (IE)
Corresponding author
Selemidis, Stavros
Venue
Nature Communications
Published
2017-07-12
Volume
8
Issue
1
Pages
69-69
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2724881933
Cited by
154
References
34
Citations by year
2026: 10 · 2025: 11 · 2024: 16 · 2023: 20 · 2022: 22 · 2021: 22 · 2020: 32 · 2019: 12 · 2018: 8 · 2017: 1
FWCI
6.56
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Monash University Research Portal (Monash University) (acceptedVersion, other-oa)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
  • UniSA Research Outputs Repository (University of South Australia) (submittedVersion, cc-by)
  • Arrow@dit (Dublin Institute of Technology) (submittedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • RMIT Research Repository (RMIT University Library) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
  • NOVA (University of Newcastle Australia) (submittedVersion, cc-by)
Funders
  • Commonwealth Scientific and Industrial Research Organisation
  • Deakin University
  • Monash University
  • RMIT University
  • University of Melbourne
  • Hudson Institute of Medical Research
  • Medical Research Council
  • Australian Research Council (FT120100876, FT130100654, CE140100036)
  • National Health and Medical Research Council (1052979, 1061687, 1128276, 1122506, 1128276, CE140100036, 1079467, 1042654, 1041795, 1006017, 1072000, 1122506, 1027112, FT120100876)
  • Institute of Infection and Immunity
  • ARC Centre for Excellence in Convergent Bio-Nano Science and Technology (CE140100036)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
Keywords
hydrogen peroxide, TLR7, antiviral therapy, endosomal targeting, single-stranded RNA viruses, single-stranded DNA viruses, antiviral innate immunity, oxidative stress
MeSH terms
NADPH Oxidase 2, Animals, Antiviral Agents, Enzyme Inhibitors, Membrane Glycoproteins, Orthomyxoviridae Infections, Influenza A virus, Endosomes, Virulence, Signal Transduction, Reactive Oxygen Species, Disease Progression, Toll-Like Receptor 7, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a target for antiviral therapy. https://app.cochat.ai/papers/10.1038/s41467-017-00057-x
The paper
To, E. E., Vlahos, R., Luong, R., Halls, M. L., Reading, P. C., King, P. T., Chan, C., Drummond, G. R., Sobey, C. G., Broughton, B. R. S., Starkey, M. R., van der Sluis, R., Lewin, S. R., Bozinovski, S., O’Neill, L. A. J., Quach, T., Porter, C. J. H., Brooks, D. A., O’Leary, J. J., & Selemidis, S. (2017). Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a target for antiviral therapy. Nature Communications. https://doi.org/10.1038/s41467-017-00057-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.